5885 Hollis Street
63 articles with Amyris, Inc.
Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it plans to participate in the following upcoming investor conference in August 2019.
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that television personality, podcaster, comedian and beauty expert to the stars Jonathan Van Ness has joined Biossance as the first celebrity ambassador for the brand.
Berkeley Lights, Inc., the leader in digital cell biology, and Amyris, Inc., a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty, and Flavors & Fragrances markets, announced that they have entered into a collaboration focused on improving the production of high-value, small molecule, natural products from Amyris' microbial strains.
FLG Partners Veteran Finance Professional to Ensure Smooth Transition and Execution of SEC Filings Compliance Process
2/15/2019Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.
Amyris, Inc. today announced that it has executed an expanded agreement for its existing production contract with ADL Bionatur Solutions (MAB:ADL), through its fermentation division ADL Biopharma.
Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.
Amyris, Inc. today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd.
The San Francisco Business Times and the Silicon Valley Business Journal pulled together to create a list of the Best Places to Work in the Bay Area. Hitting the list at number 23 for large companies is biotechnology company Amyris.
Amyris, Inc. Enters Into First Product Development And Production Agreement With Royal DSM For Food And Nutrition Molecule
Amyris, Inc. Announces Multi-Year Technology Investment Agreement With Defense Advanced Research Projects Agency Worth Up To $35 Million
Amyris, Inc. To Enter Into Exclusive Cosmetic Distribution Partnership With Leading Brazil Cosmetic Retailer
Amyris, Inc. And Infectious Disease Research Institute (IDRI) Announce Agreement To Explore Testing And Development Of Amyris Materials For Use In Vaccine Adjuvant Formulations
Amyris, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference On September 9, 2015
Amyris, Inc. Set To Increase Global Growth Of Its Cosmetic Emollients Through ISO 22716 Certification
Amyris, Inc. Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready For Industrial Scale Fermentation In Less Than 12 Months
Amyris, Inc. & Genome Compiler Launch Testing Program For Pharma And Biotech Companies To Explore DNA Design And Construction Solutions